Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is -57.06% vs 155.17% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -1,529.82% vs 107.55% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 111.76% vs -5.81% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -98.62% vs 63.59% in Mar 2025
Compare Profit and Loss Results of Parmax Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
12.00
71.00
-59.00
-83.10%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
12.00
71.00
-59.00
-83.10%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
0.00
-3.00
0%
Raw Materials Consumed
13.00
50.00
-37.00
-74.00%
Power & Fuel Cost
1.00
1.00
0.00
0.00%
Employee Cost
2.00
2.00
0.00
0.00%
Operating Expenses
0.00
4.00
-4.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
15.00
62.00
-47.00
-75.81%
Operating Profit (PBDIT) excl Other Income
-3.00
9.00
-12.00
-133.33%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
-3.00
11.00
-14.00
-127.27%
Interest
1.00
1.00
0.00
0.00%
Profit before Depriciation and Tax
-4.00
9.00
-13.00
-144.44%
Depreciation
1.00
2.00
-1.00
-50.00%
Profit Before Taxation & Exceptional Items
-5.00
6.00
-11.00
-183.33%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-5.00
6.00
-11.00
-183.33%
Provision for Tax
-1.00
2.00
-3.00
-150.00%
Profit After Tax
-4.00
4.00
-8.00
-200.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-6.00
13.00
-19.00
-146.15%
Profit Available for appropriations
-10.00
18.00
-28.00
-155.56%
Appropriations
-10.00
18.00
-28.00
-155.56%
Equity Dividend (%)
0%
2%
-2.00
Earnings Per Share
-11
4.45
-15.45
-347.19%
Profit And Loss - Net Sales
Net Sales 12.11 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -57.06% vs 155.17% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -3.64 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -1,529.82% vs 107.55% in Mar 2025
Profit And Loss - Interest
Interest 1.24 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 111.76% vs -5.81% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax -4.16 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -98.62% vs 63.59% in Mar 2025
